UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 311

Sortiert nach

Targeting the epidermal growth factor receptor

British journal of cancer, 2004-08, Vol.91 (3), p.418-424

2004

Link zum Volltext

Verfügbarkeit prüfen

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

Carcinogenesis (New York), 2014-05, Vol.35 (5), p.967-973

2014

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

British journal of cancer, 2017-11, Vol.117 (11), p.1592-1599

2017

Link zum Volltext

Verfügbarkeit prüfen

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

Annals of oncology, 2013-04, Vol.24 (4), p.965-973

2013

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

Annals of oncology, 2024-06, Vol.35 (6), p.537-548

2024

Link zum Volltext

Verfügbarkeit prüfen

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

Annals of oncology, 2018-06, Vol.29, p.v103-v103

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

Annals of oncology, 2010-10, Vol.21 (10), p.1999-2004

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of carboplatin and paclitaxel in esophageal cancer

Annals of oncology, 2004-06, Vol.15 (6), p.960-965

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2920-2925

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic tumors of pancreatobiliary origin

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S62-S62

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Annals of oncology, 2017-06, Vol.28, p.iii150-iii150

2017

Link zum Volltext

Verfügbarkeit prüfen

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer

Oncogene, 2014-11, Vol.33 (47), p.5450-5456

2014

Link zum Volltext

Verfügbarkeit prüfen

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii433-viii433

2018

Link zum Volltext

Verfügbarkeit prüfen

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Annals of oncology, 2018-10, Vol.29, p.viii42-viii42

2018

Link zum Volltext

Verfügbarkeit prüfen

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii109-ii109

2016

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S106-S107

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective open-label single center study of safety and efficacy of glass-based Y90 radioembolization for infiltrative HCC with PVT

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S90-S90

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S103-S104

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival trends in unresectable hepatocellular carcinoma and the effect of DEB-TACE: surveillance, epidemiology and end results database vs. tertiary cancer center

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.S25-S26

2014

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

British journal of cancer, 2013-03, Vol.108 (4), p.762-765

2013

Link zum Volltext

Verfügbarkeit prüfen

Developments in the Systemic Therapy of Pancreatic Cancer

Cancer investigation, 2003, Vol.21 (1), p.73-86

2003

Link zum Volltext

Verfügbarkeit prüfen

Survivals and predictive factors of atypical unresectable hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S173-S174

2013

Link zum Volltext

Verfügbarkeit prüfen

The therapeutic dilemma of BCLC C hepatocellular carcinoma (HCC): an interventional oncology-based approach

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S176-S176

2013

Link zum Volltext

Verfügbarkeit prüfen

Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S170-S171

2013

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal quality of life assessment of patients with hepatic metastatic colorectal adenocarcinoma after treatment with transarterial radioembolization Yttrium-90 therapy

Journal of vascular and interventional radiology, 2013-04, Vol.24 (4), p.S37-S37

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(265)

Publikationsform

Artikel
(309)
Buchkapitel
(2)

Sprache

Englisch
(311)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Life Sciences & Biomedicine
(121)
Oncology
(107)
Humans
(91)
Female
(61)
Male
(51)
Middle Aged
(50)
Aged
(42)
Adult
(36)
Tumors
(29)
Chemotherapy
(26)
Radiology
(23)
Cancer
(22)
Pancreatic Cancer
(22)
Biological And Medical Sciences
(20)
Pancreatic Neoplasms - Drug Therapy
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Medical Sciences
(19)
Patients
(19)
Treatment Outcome
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Targeting the epidermal growth factor receptor

Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours

mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC)

A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers

A phase II study of carboplatin and paclitaxel in esophageal cancer

Phase II Study of Gemcitabine, Cisplatin, and Infusional Fluorouracil in Advanced Pancreatic Cancer

Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic tumors of pancreatobiliary origin

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer

Sites of metastasis and association with clinical outcome (CO) in advanced stage cancer patients (pts) treated with immunotherapy (IO)

Sarcopenia and inflammation predicts survival in advanced stage cancer patients (pts) treated with immunotherapy (IO)

PD-019ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045)

Prospective open-label single center study of safety and efficacy of glass-based Y90 radioembolization for infiltrative HCC with PVT

Survival trends in chemorefractory unresectable intrahepatic cholangiocarcinoma and the effect of resin-based Yttrium-90 radioembolization: surveillance, epidemiology and end results database vs. tertiary cancer center

Survival trends in unresectable hepatocellular carcinoma and the effect of DEB-TACE: surveillance, epidemiology and end results database vs. tertiary cancer center

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

Developments in the Systemic Therapy of Pancreatic Cancer

Survivals and predictive factors of atypical unresectable hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

The therapeutic dilemma of BCLC C hepatocellular carcinoma (HCC): an interventional oncology-based approach

Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

Longitudinal quality of life assessment of patients with hepatic metastatic colorectal adenocarcinoma after treatment with transarterial radioembolization Yttrium-90 therapy

Suchergebnisse filtern